Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With
                    <scp>VEXAS</scp>
                    Syndrome: An International Multicenter Study

Eviatar, Tali; Capelusnik, Dafne; Campochiaro, Corrado; Lacombe, Valentin; Jachiet, Vincent; Zisapel, Michael; Sagy, Iftach; E. Tayer‐Shifman, Oshrat; Ozeri, David; Kivity, Shaye; Tomelleri, Alessandro; Terrier, Benjamin; Peleg, Hagit; Comont, Thibault; Sacre, Karim; Woaye‐Hune, Pascal; Arnaud, Laurent; Lazaro, Estibaliz; Grobost, Vincent; Lifermann, Francois; Samson, Maxime; Ardois, Samuel; Garnier, Alice; Maria, Alexandre; Cantagrel, Alain; Meyer, Aurore; Bouaziz, Jean‐David; Heiblig, Mael; Dagna, Lorenzo; Diral, Elisa; Kosmider, Olivier; Elkayam, Ori; Hadjadj, Jérôme; Georgin‐Lavialle, Sophie; Fain, Olivier; Mekinian, Arsene

doi:10.1002/art.43384

Public

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

Shared by NobleBlocks on Dec 12, 2025 • 12:00 AM UTC

Authors:

Tali Eviatar

Dafne Capelusnik

Corrado Campochiaro

Abstract

Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with V...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!